Fosfomycin sodium
Fosfomycin Sodium is a broad-spectrum antibiotic that inhibits the first stage of bacterial cell wall synthesis. Researchers utilize this API to study the inactivation of the MurA enzyme and its efficacy against resistant Gram-negative pathogens.
Description
Commercial & Supply Terms
- • Minimum Order Quantity (MOQ): 5 kg / Sample Available Upon Request
- • Standard Packaging: Double PE inner bags, Aluminum foil vacuum sealed, Fiber Drum (Pharma-grade protection)
- • Supply & Export Capacity: In Stock, Ready for Global Wholesale Export (FOB / CIF Terms)
- • Quality Certifications: USP / EP / BP Standard, GMP Compliant Production Chain
Comprehensive Product Overview
In the evolving field of clinical pharmacology, the distinct chemical architecture of Fosfomycin Sodium allows it to interfere directly with bacterial cell wall biosynthesis at an early stage. Specifically, this API acts by irreversibly inhibiting the enzyme UDP-N-acetylglucosamine enolpyruvyl transferase (MurA). Additionally, researchers and developers select this molecule because its minimal cross-resistance profile protects therapeutic integrity across complex formulations. Therefore, whether you develop injectable anti-infectives or specialized clinical trials, this API delivers reliable biochemical support under strict laboratory and manufacturing conditions.
Zyntex maintains a transparent production chain to ensure USP / EP / BP compliance for every pharmaceutical batch. Moreover, our quality control team verifies every lot for microbiological purity, heavy metal limits, and pyrogen levels. For instance, we optimize the particle morphology and powder flow to improve the blending efficiency in sterile reconstitution lines. As a result, your facility receives a pure, non-pyrogenic reagent for advanced anti-infective research and development.
Modern clinical science relies on high-purity active ingredients to combat resistant bacterial strains and support patient recovery. Because Fosfomycin Sodium possesses documented synergistic properties with other classes of antibiotics, it remains a cornerstone for combination therapy research and systemic infection management. Ultimately, Zyntex provides a dependable foundation for your next pharmaceutical breakthrough in parenteral drug delivery.
Specialized Pharmaceutical Applications
This critical active ingredient is vital for the following specialized clinical and research sectors:
🛡️ Anti-Infective Research
Scientists use Fosfomycin Sodium to investigate novel mechanisms against multi-drug resistant gram-positive and gram-negative pathogens.
💉 Parenteral Formulation
Formulators utilize its high aqueous solubility to design fast-acting intravenous solutions and systemic infusion protocols.
🧪 Enzyme Inhibition Studies
Researchers rely on this compound to study cell wall synthesis interruption via MurA enzyme blocking pathways.
⚡ Combination Therapy
This API serves as a vital benchmark component for evaluating synergistic bactericidal effects in complex clinical models.
Technical Specifications
| Parameter | Specification Standard |
|---|---|
| Product Name | Fosfomycin Sodium |
| CAS Number | 26016-99-9 |
| Molecular Formula | C3H7NaO4P |
| Purity | Pharma Grade (Min. 98.0% – 102.0%) |
| Appearance | White Crystalline Powder or Hygroscopic Crystals |
🔬 Scientific Data: For detailed handling, metabolic pathways, and safety data, consult: PubChem Entry: Fosfomycin Sodium (External Link)
